AVANÇOS PROMISSORES NA OTIMIZAÇÃO DO TRATAMENTO DE AUTISMO: EXPLORANDO ABORDAGENS E ESTRATÉGIAS EFETIVAS
DOI:
https://doi.org/10.61164/rmnm.v13i1.1989Keywords:
Transtorno Autístico, Transtorno do Espectro Autista, Tratamento Farmacológico, diagnóstico.Abstract
Early diagnosis is essential to allow early interventions, favoring the improvement of the clinical condition and the individual's development. In addition to pharmacological approaches, behavioral, occupational and speech therapies also play a fundamental role in the treatment of ASD. Despite the absence of effective medications for the core symptoms of autism, some drugs have been used to help patients face challenges and improve their quality of life. It is essential that there is multidisciplinary monitoring to ensure personalized and safe treatment, involving a multidisciplinary team, combining behavioral, occupational and speech therapies, with the appropriate use of medications when necessary. The objective of this study is to identify treatments for autism spectrum disorder (ASD) that have the most evidence and effectiveness. Research was conducted using a bibliographic review based on the mentioned theme. However, research is still needed to investigate new pharmacological treatments and the development of specific medications for ASD, aiming to improve the quality of life and social inclusion of individuals.
Downloads
References
AL-DEWIK, N. I. Risk factors diagnosis, prognosis and treatment of autism. Frontiers in Bioscience, v. 25, n. 9, p. 1682–1717, 2020. DOI: https://doi.org/10.2741/4873
ALMEIDA, M. S. C. et al. Classificação Internacional das Doenças – 11 revisão. Revista de Saúde Pública, v. 54, p. 104, 14 dez. 2020. DOI: https://doi.org/10.11606/s1518-8787.2020054002120
AMERICAN PSYCHIATRIC ASSOCIATION. Manual Diagnóstico e Estatístico de Transtornos Mentais - DSM-5-TR. Porto Alegre, Artmed, 2023.
AUTISTIC PERSONS. ID on line Revista de psicologia, v. 15, n. 56, p. 163–175, 31 jul. 2021. DOI: https://doi.org/10.14295/idonline.v15i56.3131
BRITO, N. O. R. et al. Avaliação da eficácia da Risperidona comparada ao placebo e ao Aripiprazol no tratamento da agressividade em pacientes autistas: revisão sistemática. repositório.aee.edu.br, 21 jun. 2021.
ECKES, T. et al. Comprehensive ABA-based interventions in the treatment of children with autism spectrum disorder – a meta-analysis. BMC Psychiatry, v. 23, n. 1, 2 mar. 2023. DOI: https://doi.org/10.1186/s12888-022-04412-1
MASINI, E. et al. An Overview of the Main Genetic, Epigenetic and Environmental Factors Involved in Autism Spectrum Disorder Focusing on Synaptic Activity. International Journal of Molecular Sciences, v. 21, n. 21, p. 8290, 5 nov. 2020. DOI: https://doi.org/10.3390/ijms21218290
OLIVEIRA, C. A. DE et al. Eficácia do uso da Fluoxetina no Tratamento do Transtorno dos Comportamentos Obsessivo-Compulsivo em Autistas / Effectiveness of Fluoxetine use in the Treatment of Obsessive-Compulsive Behavior Disorders in
OSHIMA, F. et al. Cognitive behavior therapy for autistic adolescents, awareness and care for my autistic traits program: a multicenter randomized controlled trial. BMC Psychiatry, v. 23, p. 661, 7 set. 2023. DOI: https://doi.org/10.1186/s12888-023-05075-2
PEREIRA, E. T. et al. Comunicação alternativa e aumentativa no transtorno do espectro do autismo: impactos na comunicação. CODAS, v. 32, n. 6, 2020. DOI: https://doi.org/10.1590/2317-1782/20202019167
REIS, R. DE C. et al. Association of Parental Support with Reduced Stereotypy in Children with Autism Spectrum Disorder: A Cross-Sectional Study. Medicina, v. 59, n. 9, p. 1667, 15 sets. 2023. DOI: https://doi.org/10.3390/medicina59091667
REYES, E.; PIZARRO, L. Rol de la terapia farmacológica en los trastornos del espectro autista. Revista Médica Clínica Las Condes, v. 33, n. 4, p. 387–399, jul. 2022. DOI: https://doi.org/10.1016/j.rmclc.2022.07.002
ROSEN, N. E.; LORD, C.VOLKMAR, F.O.R. The Diagnosis of Autism: From Kanner to DSM-III to DSM-5 and Beyond. Journal of Autism and Developmental Disorders, v. 51, n. 12, 24 fev. 2021. DOI: https://doi.org/10.1007/s10803-021-04904-1
RUGGIERI, V. Autismo. Pharmacological treatment. Medicina, v. 83 Suppl 4, p. 46–51, 1 set. 2023.
SILVA, A. R. C. E. DA; BATISTA, D. C. DE À. Distúrbios comportamentais associados ao transtorno do espectro autista (TEA) - tratamento farmacológico e o manejo clínico de reações adversas. Revista Multidisciplinar do Sertão, v. 4, n. 3, p. 276–285, 30 set. 2022.
VIANA, A. C. V. et al. Autismo: Saúde dinâmica, v. 2, n. 3, p. 1–18, 18 nov. 2020. DOI: https://doi.org/10.4322/2675-133X.2022.017
XIONG, M. et al. Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis. Neuropediatrics, v. 54, n. 3, p. 167–173, 24 fev. 2023. DOI: https://doi.org/10.1055/s-0043-1761437
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
